About: A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 1995 (uk) im April 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 1995 (ast) scientific article published on 01 April 1995 (en)
publication date	wds:Q72116943-4F6C1FF9-06C0-47DF-9F4A-C730279F19F0
publication date	1995-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72116943-8F73072F-61CC-4664-9CF7-EDDE162C3750
language of work or name	English
cites work	wds:Q72116943-048D1A65-E0C0-4705-BA27-27D2258658D0 wds:Q72116943-4697B106-BE96-49B0-96C2-FA3FD69B2597 wds:Q72116943-46D7CB59-7BCD-4D4E-87A4-60721F2989D8 wds:Q72116943-5BCE76BC-8B1E-42D7-A419-CF078090F965 wds:Q72116943-685B9D63-EC4C-4B42-92C7-C4022FCBB1FC wds:Q72116943-7D31AE34-408D-4CC8-A4BE-5463C49C3987 wds:Q72116943-D29A0553-3B72-4C29-B0E3-45FF626EE401 wds:Q72116943-E5C2211C-5A77-4573-B300-C0ADF15FABB5 wds:Q72116943-E69F7C28-5708-4FE9-834F-BEB13EB01A18 wds:Q72116943-F78FC215-099B-4074-A7D9-5FBCD6F00255 wds:Q72116943-FD8BF211-C42D-422A-ABE4-B1DDAFD8A4FE
cites work	Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study Hypogammaglobulinemia in patients with cystic fibrosis Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa Bronchial hyperreactivity in cystic fibrosis and asthma Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. A 5 YEAR CLINICAL EVALUATION OF A THERAPEUTIC PROGRAM FOR PATIENTS WITH CYSTIC FIBROSIS. Risk factors for the development of posterior subcapsular cataracts in patients with cystic fibrosis and allergic bronchopulmonary aspergillosis treated with corticosteroids Altered prednisolone pharmacokinetics in patients with cystic fibrosis Ocular findings in cystic fibrosis Corticosteroid treatment in cystic fibrosis
author name string	wds:Q72116943-6FB4B455-1070-46A4-8F4D-5FF976154F2F wds:Q72116943-72B6F7A6-85B9-4ED6-8D65-3266A25C958E wds:Q72116943-CA642779-B741-4BBD-8ADF-A3CEF54C3EA3 wds:Q72116943-F17F3AAD-1D19-45BD-9CD8-8EBB162F42D6
author name string	D V Schidlow H Eigen B J Rosenstein S FitzSimmons
rdfs:label	A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group (en) A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group (nl)
skos:prefLabel	A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group (en) A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group (nl)
name	A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group (en) A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group (nl)
title	wds:Q72116943-317125BE-6D30-4550-AC2E-4DEA06DF2B5B
title	A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group (en)
page(s)	wds:Q72116943-F9BF5AFC-645B-4E0C-952A-1EA7EA805AA7
page(s)	515-523
instance of	wds:Q72116943-4A24224A-5C09-4768-B483-3FAAAB2B5697
instance of	scholarly article
main subject	wds:Q72116943-5B8837D9-3E4D-47A7-B757-AA093419D04C wds:Q72116943-AD9D9CCB-3F7E-41C5-9AE4-7B0183E064AC
main subject	multicenter clinical trial cystic fibrosis
PubMed ID	wds:Q72116943-4521DA85-DDDA-447A-B149-8F16FAB01A51
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7699528
PubMed ID	7699528
published in	wds:Q72116943-A8B6ACE0-CCA8-429D-BFB6-8B7EF1128549
published in	The Journal of Pediatrics
issue	wds:Q72116943-54B2F533-B961-4F76-9E44-304E84E463C0
volume	wds:Q72116943-00F8BFF6-6C91-4369-88F1-68A45083AD61
issue	4
volume	126
DOI	wds:Q72116943-2A900B82-1D07-4CC4-87CB-A48C92095CB5
DOI	http://dx.doi.org/10.1016/S0022-3476(95)70343-8
DOI	10.1016/S0022-3476(95)70343-8
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72116943
is cites work of	Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis Proteases and cystic fibrosis Oral steroids for cystic fibrosis Cystic Fibrosis Adult Care Predictive 5-year survivorship model of cystic fibrosis Cystic fibrosis Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth Clinical significance of microbial infection and adaptation in cystic fibrosis Drug use in children: cohort study in three European countries Heritability of lung disease severity in cystic fibrosis "CF asthma": what is it and what do we do about it? Cystic fibrosis Exacerbations in cystic fibrosis: 2 . prevention. Sputum biomarkers of inflammation in cystic fibrosis lung disease Highlights of a workshop to discuss targeting inflammation in cystic fibrosis Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice Advancing outcome measures for the new era of drug development in cystic fibrosis Oral steroids for long-term use in cystic fibrosis Oral steroids for long-term use in cystic fibrosis Progress in therapies for cystic fibrosis Lung infections associated with cystic fibrosis Antibiotic and anti-inflammatory therapies for cystic fibrosis Cystic fibrosis Quality of life in children and adolescents with cystic fibrosis: implications for optimizing treatments and clinical trial design Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis Relationship between disease severity and inflammatory markers in cystic fibrosis Potential of anti-inflammatory treatment for cystic fibrosis lung disease Improving rate of decline of FEV1 in young adults with cystic fibrosis Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software